Cargando…

Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series

Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic shock. Although the administration of a high dose of vasopressin needs to be avoided, the effects of bolus loading have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kensuke, Nakano, Hidehiko, Naraba, Hiromu, Mochizuki, Masaki, Takahashi, Yuji, Sonoo, Tomohiro, Hashimoto, Hideki, Abe, Toshikazu, Hayakawa, Mineji, Yamakawa, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129171/
https://www.ncbi.nlm.nih.gov/pubmed/34017842
http://dx.doi.org/10.3389/fmed.2021.644195
_version_ 1783694269452648448
author Nakamura, Kensuke
Nakano, Hidehiko
Naraba, Hiromu
Mochizuki, Masaki
Takahashi, Yuji
Sonoo, Tomohiro
Hashimoto, Hideki
Abe, Toshikazu
Hayakawa, Mineji
Yamakawa, Kazuma
author_facet Nakamura, Kensuke
Nakano, Hidehiko
Naraba, Hiromu
Mochizuki, Masaki
Takahashi, Yuji
Sonoo, Tomohiro
Hashimoto, Hideki
Abe, Toshikazu
Hayakawa, Mineji
Yamakawa, Kazuma
author_sort Nakamura, Kensuke
collection PubMed
description Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic shock. Although the administration of a high dose of vasopressin needs to be avoided, the effects of bolus loading have not yet been examined. Since the half-life of vasopressin is longer than that of catecholamines, we hypothesized that vasopressin loading may be effective for predicting responses to its continuous administration. Methods: We retrospectively analyzed consecutive cases of septic shock for which vasopressin was introduced with loading under noradrenaline at >0.2 μg/kg/min during the study period. Vasopressin was administered in a 1 U bolus followed by its continuous administration at 1 U/h. The proportion of patients with a negative catecholamine index (CAI) change 6 h after the introduction of vasopressin was set as the primary outcome. We defined non-responders for exploration as those with a mean arterial pressure change <18 mmHg 1 min after vasopressin loading, among whom none had a change in CAI <0. Results: Twenty-one consecutive cases were examined in the present study, and included 14 responders and 7 non-responders. The primary outcome accounted for 71.4% of responders and 0% of non-responders, with a significant difference (p = 0.0039). Median CAI changes 2, 4, and 6 h after the administration of vasopressin were 0, −5, and −10 in responders and +20, +10, and +10 in non-responders, respectively. CAI was not reduced in any non-responder. Outcomes including mortality were not significantly different between responders and non-responders. Digital ischemia (1/21) and mesenteric ischemia (1/21) were observed. Conclusions: Vasopressin loading may predict responses to its continuous administration in septic shock patients. Further investigations involving a safety analysis are needed.
format Online
Article
Text
id pubmed-8129171
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81291712021-05-19 Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series Nakamura, Kensuke Nakano, Hidehiko Naraba, Hiromu Mochizuki, Masaki Takahashi, Yuji Sonoo, Tomohiro Hashimoto, Hideki Abe, Toshikazu Hayakawa, Mineji Yamakawa, Kazuma Front Med (Lausanne) Medicine Background: Vasopressin is one of the strong vasopressor agents associated with ischemic events. Responses to the administration of vasopressin differ among patients with septic shock. Although the administration of a high dose of vasopressin needs to be avoided, the effects of bolus loading have not yet been examined. Since the half-life of vasopressin is longer than that of catecholamines, we hypothesized that vasopressin loading may be effective for predicting responses to its continuous administration. Methods: We retrospectively analyzed consecutive cases of septic shock for which vasopressin was introduced with loading under noradrenaline at >0.2 μg/kg/min during the study period. Vasopressin was administered in a 1 U bolus followed by its continuous administration at 1 U/h. The proportion of patients with a negative catecholamine index (CAI) change 6 h after the introduction of vasopressin was set as the primary outcome. We defined non-responders for exploration as those with a mean arterial pressure change <18 mmHg 1 min after vasopressin loading, among whom none had a change in CAI <0. Results: Twenty-one consecutive cases were examined in the present study, and included 14 responders and 7 non-responders. The primary outcome accounted for 71.4% of responders and 0% of non-responders, with a significant difference (p = 0.0039). Median CAI changes 2, 4, and 6 h after the administration of vasopressin were 0, −5, and −10 in responders and +20, +10, and +10 in non-responders, respectively. CAI was not reduced in any non-responder. Outcomes including mortality were not significantly different between responders and non-responders. Digital ischemia (1/21) and mesenteric ischemia (1/21) were observed. Conclusions: Vasopressin loading may predict responses to its continuous administration in septic shock patients. Further investigations involving a safety analysis are needed. Frontiers Media S.A. 2021-05-04 /pmc/articles/PMC8129171/ /pubmed/34017842 http://dx.doi.org/10.3389/fmed.2021.644195 Text en Copyright © 2021 Nakamura, Nakano, Naraba, Mochizuki, Takahashi, Sonoo, Hashimoto, Abe, Hayakawa and Yamakawa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Nakamura, Kensuke
Nakano, Hidehiko
Naraba, Hiromu
Mochizuki, Masaki
Takahashi, Yuji
Sonoo, Tomohiro
Hashimoto, Hideki
Abe, Toshikazu
Hayakawa, Mineji
Yamakawa, Kazuma
Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
title Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
title_full Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
title_fullStr Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
title_full_unstemmed Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
title_short Vasopressin Loading for Refractory Septic Shock: A Preliminary Analysis of a Case Series
title_sort vasopressin loading for refractory septic shock: a preliminary analysis of a case series
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129171/
https://www.ncbi.nlm.nih.gov/pubmed/34017842
http://dx.doi.org/10.3389/fmed.2021.644195
work_keys_str_mv AT nakamurakensuke vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT nakanohidehiko vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT narabahiromu vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT mochizukimasaki vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT takahashiyuji vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT sonootomohiro vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT hashimotohideki vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT abetoshikazu vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT hayakawamineji vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries
AT yamakawakazuma vasopressinloadingforrefractorysepticshockapreliminaryanalysisofacaseseries